Visão selecionada em Inglês
Descritor em português: | Carboxipeptidase B2 | ||||||
Descritor em inglês: | Carboxypeptidase B2 | ||||||
Descritor em espanhol: |
Carboxipeptidasa B2
| ||||||
Descritor em francês: | Carboxypeptidase B2 | ||||||
Termo(s) alternativo(s): |
Arginine Carboxypeptidase Carboxypeptidase B2, Plasma Carboxypeptidase R Carboxypeptidase U Plasma Carboxypeptidase B2 Plasma Procarboxypeptidase B Procarboxypeptidase U Thrombin Activatable Fibrinolysis Inhibitor Thrombin-Activatable Fibrinolysis Inhibitor Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) |
||||||
Código(s) hierárquico(s): |
D08.811.277.656.350.245.125 D08.811.277.656.350.555.225 D08.811.277.656.675.555.225 D08.811.277.656.837.092 |
||||||
Identificador Único RDF: | https://id.nlm.nih.gov/mesh/D025901 | ||||||
Nota de escopo: | A carboxypeptidase that removes C-terminal lysine or arginine from peptides and proteins. Carboxypeptidase B2 (CPB2) is released into the circulation as a proenzyme which is activated by the THROMBIN-THROMBOMODULIN complex. Activated CPB2 is involved in modulating a variety of processes by cleaving and inactivating various circulating proteins and peptides that are its substrates including FIBRIN; KININS; and ANAPHYLATOXINS. |
||||||
Qualificadores permitidos: |
AD administration & dosage AE adverse effects AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
Número de registro: | EC 3.4.17.20 | ||||||
Indexação Anterior: |
Carboxypeptidases (1979-2001) Lysine Carboxypeptidase (1994-2001) |
||||||
Nota MeSH pública: | 2015; see CARBOXYPEPTIDASE U 2002-2014; CARBOXYPEPTIDASE U (NM) was indexed under CARBOXYPEPTIDASES 1994-2001; for ARGININE CARBOXYPEPTIDASE see LYSINE CARBOXYPEPTIDASE 1997-2001 |
||||||
Nota histórica: | 2015 (2002); use CARBOXYPEPTIDASE U (NM) 1994-2001 and LYSINE CARBOXYPEPTIDASE 1997-2001 |
||||||
Identificador DeCS: | 36082 | ||||||
ID do descritor: | D025901 | ||||||
Documentos indexados na Biblioteca Virtual em Saúde (BVS): | Clique aqui para acessar os documentos da BVS | ||||||
Data de estabelecimento: | 01/01/2002 | ||||||
Data de entrada: | 25/07/2001 | ||||||
Data de revisão: | 06/06/2014 |
-
-
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes -
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes -
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes -
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes
|
Carboxypeptidase B2
- Conceito preferido
Procarboxypeptidase U
- Relacionado, mas não mais amplo ou mais específico
Identificador do conceito |
M0376430 |
Nota de escopo | A carboxypeptidase that removes C-terminal lysine or arginine from peptides and proteins. Carboxypeptidase B2 (CPB2) is released into the circulation as a proenzyme which is activated by the THROMBIN-THROMBOMODULIN complex. Activated CPB2 is involved in modulating a variety of processes by cleaving and inactivating various circulating proteins and peptides that are its substrates including FIBRIN; KININS; and ANAPHYLATOXINS. |
Termo preferido | Carboxypeptidase B2 |
Termo(s) alternativo(s) |
Arginine Carboxypeptidase Carboxypeptidase B2, Plasma Carboxypeptidase R Carboxypeptidase U Plasma Carboxypeptidase B2 Thrombin Activatable Fibrinolysis Inhibitor Thrombin-Activatable Fibrinolysis Inhibitor Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) |
Identificador do conceito |
M0368256 |
Termo preferido | Procarboxypeptidase U |
Termo(s) alternativo(s) |
Plasma Procarboxypeptidase B |
Queremos a sua opinião sobre o novo sitio web do DeCS/MeSH
Convidamos-lhe a responder a uma pesquisa que não levará mais que 3 minutos
Ir para pesquisa